109 related articles for article (PubMed ID: 3160477)
1. Failure of percutaneous transluminal coronary angioplasty to stimulate platelet and prostaglandin activity.
Stine RA; Magorien RD; Bush CA; Kolibash AJ; Leier CV; Fertel RH; Brandt J; Unverferth DV
Cathet Cardiovasc Diagn; 1985; 11(3):247-54. PubMed ID: 3160477
[TBL] [Abstract][Full Text] [Related]
2. [Effect of chuan-xiong granules on platelet aggregation, plasma beta-thromboglobulin, platelet factor IV, thromboxane B2 and 6-keto-prostaglandin F1 alpha in coronary disease patients].
Yu Z; Chen KJ
Zhong Xi Yi Jie He Za Zhi; 1987 Jan; 7(1):8-11, 3. PubMed ID: 2954711
[No Abstract] [Full Text] [Related]
3. Effects of treadmill and pacing stress testing on peripheral arterial thromboxane, platelet function and catecholamine activities in patients with chronic coronary artery disease.
Kurita A; Satomura K; Takase B; Sugawara H; Hosono K
Jpn J Med; 1987 Feb; 26(1):7-14. PubMed ID: 2952824
[TBL] [Abstract][Full Text] [Related]
4. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
[TBL] [Abstract][Full Text] [Related]
5. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
[TBL] [Abstract][Full Text] [Related]
6. Release of platelet activation markers during coronary angioplasty.
Korovesis S; Fredericks S; Holt D; Toutouzas P; Kaski JC; Webb-Peploe MM; Katritsis D
Coron Artery Dis; 2000 Jul; 11(5):391-8. PubMed ID: 10895405
[TBL] [Abstract][Full Text] [Related]
7. Platelet aggregation, coronary artery disease progression and future coronary events.
Lam JY; Latour JG; Lespérance J; Waters D
Am J Cardiol; 1994 Feb; 73(5):333-8. PubMed ID: 8109546
[TBL] [Abstract][Full Text] [Related]
8. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
[TBL] [Abstract][Full Text] [Related]
9. Severe intracoronary thromboxane release preceding acute coronary artery occlusion.
Mehta J; Mehta P; Feldman RL
Prostaglandins Leukot Med; 1982 Jun; 8(6):599-605. PubMed ID: 6955814
[TBL] [Abstract][Full Text] [Related]
10. Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
Vaitkus PT; Watkins MW; Witmer WT; Tracy RP; Sobel BE
Coron Artery Dis; 1995 Jul; 6(7):587-92. PubMed ID: 7582198
[TBL] [Abstract][Full Text] [Related]
11. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
[TBL] [Abstract][Full Text] [Related]
12. [Newly developed stenocardia: functional activity of thrombocytes].
Shalaev SV; Panchenko EP; Masenko VP; Smirnov IE; Vinogradova IV
Kardiologiia; 1988 Jul; 28(7):63-8. PubMed ID: 2974904
[TBL] [Abstract][Full Text] [Related]
13. [Responses of plasma eicosanoids and hemodynamics to myocardial ischemia and the salutary effect of calcium entry blocker].
Takase B
Nihon Ika Daigaku Zasshi; 1990 Feb; 57(1):42-54. PubMed ID: 2329180
[TBL] [Abstract][Full Text] [Related]
14. Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease.
Roy L; Mehta J; Mehta P
Am Heart J; 1985 May; 109(5 Pt 1):1026-31. PubMed ID: 3158183
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the effects of catheter sampling for the study of platelet behavior in the pulmonary and coronary circulation.
Bugiardini R; Chierchia S; Crea F; Gallino A; Wild S; Roskovec A; Lenzi S; Maseri A
Am Heart J; 1984 Aug; 108(2):255-60. PubMed ID: 6205577
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Ligusticum wallichii on the plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2 and 6-keto-PGF1 alpha in rabbits under acute experimental cerebral ischemia].
Liu Z
Zhong Xi Yi Jie He Za Zhi; 1990 Sep; 10(9):543-4, 517-8. PubMed ID: 2148509
[TBL] [Abstract][Full Text] [Related]
17. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
Mathieu P; Villemot JP; Stoltz JF; Scheck F; Garnier LF
Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
[TBL] [Abstract][Full Text] [Related]
18. [Alteration of prostaglandin metabolism in alcoholic liver disease: its association with platelet dysfunction after chronic alcohol ingestion].
Arai M; Okuno F; Ishii H; Hirano Y; Sujita K; Kobayashi T; Takagi T; Maruyama K; Kato S; Tsugu M
Nihon Shokakibyo Gakkai Zasshi; 1989 Feb; 86(2):220-6. PubMed ID: 2526889
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226
[No Abstract] [Full Text] [Related]
20. Thromboxane release during percutaneous transluminal coronary angioplasty.
Peterson MB; Machaj V; Block PC; Palacios I; Philbin D; Watkins WD
Am Heart J; 1986 Jan; 111(1):1-6. PubMed ID: 2936225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
